Effects of absorption enhancers on intestinal absorption of lumbrokinase

Yaoxue Xuebao

Volumn 41, Issue 10, 2006, Pages 939-944

  Li, Yu Hua ^a   Zhang, Mo ^a   Wang, Jian Cheng ^a   Zhang, Shu ^a   Liu, Jian Rong ^b   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Baiao Pharmaceuticals Co Ltd   (China)

Author keywords

Absorption enhancer; Intestinal absorption; Lumbrokinase; Pharmacokinetics

Indexed keywords

CHITOSAN; DEOXYCHOLIC ACID; EDETIC ACID; LUMBROKINASE; OCTANOIC ACID; OCTANOIC ACID DERIVATIVE; POLOXAMER; PROTEINASE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; DRUG EFFECT; DUODENUM; INTESTINE ABSORPTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLIC CLEARANCE RATE; METABOLISM; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; CHITOSAN; DEOXYCHOLIC ACID; DUODENUM; EDETIC ACID; ENDOPEPTIDASES; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALE; METABOLIC CLEARANCE RATE; OCTANOIC ACIDS; POLOXAMER; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33845357587     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yang L, Li JZ. Fibrinogen and thrombus diseases [J]. Chin J Hematol, 1999, 20:163-165.
2. Hrzenjak T, Popovic M, Bozic T, et al. Fibrinolytic and anticoagulative activities from the earthworm, Eiseriafoetida [J]. Comp Biochem Physiol, 1998, 119B:825-832.
3. Xing BD, Yin SM, Ru BG. Purification and characterization of the fibrinolytic enzyme (eFE-D) from earthworm eiaenia folelide [J]. Acta Biochim Biophys Sin, 1997, 29:609-611.
4. Yan XY, Zhang XN, Zhang Q. Absorption of recombinant hirudin in rats GI tract [J]. Acta Pharm Sin, 2004, 39:77-80.
5. Li G, Fang C. Biological study methods of drug intestinal absorption [J]. Chin Pharm J, 2002, 37:726-729.
6. Dong LY, Fan L, Chen ZW, et al. Effects of reteplase on fibrinolytic and coagulation systems in rabbits [J]. Chin J Clin Pharmaool Ther, 2004, 9:778-780.
7. Toshikiro K, Yusuke M, Misako O, et al. Gastroin-testinal absorption of recombinant human insulin-like growth factor-I in rats [J]. J Pharmcol Exp Ther, 1997, 283:611-618.
8. Dong XH, Han YW, Xu L, et al. Study of zinc cheated ammonia acid in different intestinal fragments [J]. Heilongjiang J Anim Sci Vet Med, 2002, 1:6-8.
9. Nakajima N, Mihara H, Sumi H. Characterization of potent fibrinolytic enzymes in earthworm, lumbricus rubellus [J]. Biosci Biotech Biochem, 1993, 57:1726-1730.
10. Fan Q, Wu C, Li L, et al. Characters of EFE-III-1 in intestinal absorption [J]. Biochim Biophys Acta, 2001, 152:286-292.
11. 2 EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery [J]. Pharm Res, 1988, 5:305-308.
12. Uchiyama T, Sugiyama T, Quan YS, et al. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers; their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-β-Z)-maltopyanoside [J]. J Pharm Pharmacol, 1999, 51:1241-1250.
13. Xu C, Zhang JS. Immunocolloidal gold microscopic study on the mechanism of sodium cholate in enhancing insulin colonie absorption [J]. Acta Pharm Sin, 2004, 39:477-480.
14. Ji HY, Li ZZ, Sun JR. Absorption mechanisms of protein and peptide in oral administration [J]. Shandong Pharm Ind, 2003, 22:31-32.